IONS
NASDAQ
$53.39
Ionis Pharmaceuticals Inc (IONS)
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapies in the United States. The company is headquartered in Carlsbad, California.
Sector:
Healthcare
Industry:
Biotechnology
Buy
Target: $92.95 (+74.10%)
Market Cap
$9.08B
FCF 5Y CAGR
+90.22%
Free Cash Flow Yield
-10.70%
Beta (5Y)
0.65
Price Chart
Valuation
Market Cap$9.08B
Forward P/E90.91
P/S8.58
P/B19.09
Profitability
Total Revenue (TTM)$1.06B
Gross Profit (TTM)$116M
EBITDA-$341M
Profit Margin-37.6%
Operating Margin-47.7%
EPS-$1.05
Financial Health
Debt-to-Equity88%
Free Cash Flow Yield-10.70%
Growth & Risk
EPS 5Y CAGR-21.44%
Revenue 5Y CAGR+8.38%
FCF 5Y CAGR+90.22%
Beta (5Y)0.65
Sharpe Ratio0.61